Oral Oncology
Volume 45, Issue 1 , Pages 47-51, January 2009

Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases

  • Rohan R Walvekar

      Affiliations

    • Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
    • Department of Otolaryngology and Head Neck Surgery, University of Pittsburgh, PA 15213, United States
  • ,
  • Devendra A Chaukar

      Affiliations

    • Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
  • ,
  • Mandar S Deshpande

      Affiliations

    • Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
  • ,
  • Prathamesh S Pai

      Affiliations

    • Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
  • ,
  • Pankaj Chaturvedi

      Affiliations

    • Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
  • ,
  • Anagha Kakade

      Affiliations

    • Clinical Research Secretariat, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
  • ,
  • Subhadra V Kane

      Affiliations

    • Department of Pathology, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
  • ,
  • Anil K D’Cruz

      Affiliations

    • Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. E. Borges Marg, Parel, Mumbai 400 012, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 22 24177278; fax: +91 22 24158989.

Received 18 February 2008; received in revised form 17 March 2008; accepted 18 March 2008. published online 14 July 2008.

Summary 

This paper studies the clinical and pathological predictors of local recurrence and disease-free survival (DFS) in patients with oral verrucous carcinoma (OVC) treated surgically, through a retrospective chart review. Three hundred and two patients with OVC were identified from January 1990 to December 2000, of which, 101 surgically treated patients who fulfilled our inclusion criteria were analyzed. A univariate analysis (UVA) of important prognostic factors, patterns of recurrence, and DFS is reported. Seventy-nine patients were male (M:F ratio, 3.6:1) and the mean age at presentation was 53.9 years (range, 23–90 years). The median follow up was 4.61 years (range, 0.51–14.3 years). The incidence of tobacco chewing, smoking, and alcohol intake was 77%, 42%, and 10%, respectively. Thirty-four patients (33.7%) had either leukoplakia or submucous fibrosis (SMF) on oral cavity examination. Early-stage tumors accounted for 39.7%; while 60.4% were late-stage tumors. On UVA, tumor location, presence of a premalignant lesion, smoking, and positive margins were statistically significant. Sixty-eight percent (19/28) recurred locally. The salvage rate for recurrent tumors was 66.7% (16/28) with a median post-recurrence survival of 16 months (range, 10–83 months). The five year DFS with surgical therapy was 77.6%. OVC has an excellent prognosis with surgical treatment. The significance of positive margins emphasizes the need for adequate surgical resection. Additionally, the presence of either leukoplakia or SMF and tumor location in the upper alveolar-palatal complex is associated with worse outcomes. Neck dissection, if considered, may be limited to a supra-omohyoid neck dissection (SOHND).

Keywords: Ackerman’s tumor, Verrucous carcinoma, Oral cavity, Cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(08)00096-1

doi:10.1016/j.oraloncology.2008.03.014

Oral Oncology
Volume 45, Issue 1 , Pages 47-51, January 2009